Abstract Submissions Now Closed

The NDLR Scientific Committee have accounced abstract submissions are now closed.

Early Bird Registrations

Early bird registration opens Tuesday 5 October!
Register between 5 October 2021 and 20 January 2022 to receive the discounted rate.

Key Dates

Call for abstracts: Now Open

Registration: 5 October 2021

Abstract submission deadline: 4 November 2021

Author/early bird registration deadline: 20 January 2022

Meeting dates: 7 – 9 March 2022

Express Your Interest

Join our mailing list to be kept up to date
with information on the Meeting.


The Executive, Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, from 7-9 March, 2022.

The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.

As one of the premier international leukaemia conferences, NDLR 2022 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.

Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.

We look forward to seeing you at NDLR 2022.

Professors Deborah White & Daniel Thomas (co-chairs)

NDLR 2018 Delegates

Thank you to our Sponsors


NDLR 2022 Meeting Supporter



Principal Sponsors



Gold Sponsor


Bronze Sponsors



Scientific Poster and Notepad & Pen Sponsor